Rimegepant for endometriosis pain
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether an oral medication called rimegepant can reduce moderate to severe pain caused by endometriosis. Rimegepant is a pill that targets a protein involved in pain signaling, and it may offer a new option for managing endometriosis symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 45 years old.
- You have been diagnosed with endometriosis through surgery in the last 3 to 6 months.
- You currently have moderate to severe pelvic pain related to endometriosis.
- You are using an effective birth control method (like pills, IUD, or sterilization) and agree to keep using it during the 12-week study.
- You are not pregnant or breastfeeding, and you are willing to take urine pregnancy tests at home and in the clinic throughout the study.
- You do not have a history of heart disease, stroke, uncontrolled high blood pressure, diabetes, or severe kidney or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.
This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.
This trial tests a new drug called GenSci048 to see if it can reduce moderate to severe pain caused by endometriosis. It might be an option if you have regular periods and are willing to switch to only the pain relievers allowed in the study.
This trial is testing a medicine called Relugolix to see if it helps reduce pain related to endometriosis. If you have confirmed endometriosis and are already taking Relugolix for at least a month with significant pain, this study might be for you.
This trial tests if esketamine, a nasal spray, can reduce chronic pelvic pain in women with endometriosis that hasn't improved with standard painkillers. You may qualify if you have severe pain and are scheduled for endometriosis surgery.
This trial tests a hormone medicine called dydrogesterone (Duphaston) to see if it eases pain caused by endometriosis. It is for women with regular periods and a confirmed endometriosis diagnosis who are not using other hormone treatments.
Hear when a new Endometriosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.